Volkswagen India introduces leasing, flexible financing options to drive sales amid COVID-19

Under its omni-channel mobility solutions, the company has integrated 'Power Lease' -- a 'pay-for-usage' model complete with zero down payment scheme -- with Volkswagen Secure which allows customers to purchase a Vento or a Tiguan Allspace model with flexible down payment and low EMI, including insurance coverage for a tenure of three or four years.

May 27, 2020 / 01:04 PM IST

Volkswagen India on Wednesday introduced leasing options and flexible financing instruments for purchase of its vehicles with an aim to drive sales in a market battered by COVID-19 disruptions.

Under its omni-channel mobility solutions, the company has integrated 'Power Lease' -- a 'pay-for-usage' model complete with zero down payment scheme -- with Volkswagen Secure which allows customers to purchase a Vento or a Tiguan Allspace model with flexible down payment and low EMI, including insurance coverage for a tenure of three or four years.

Commenting on the omni-channel mobility initiative Volkswagen Passenger Cars India Director Steffen Knapp said, "with the prevailing economic situation, we, at Volkswagen would like to offer customers financial prudency through our omni-channel mobility program."

The Volkswagen Secure and Power Lease initiatives provide customers the power and independence to purchase their favourite Volkswagen in a hassle-free, contactless and digitalised manner, he added.

In the current scenario, wherein accessible individual mobility is on the rise, these solutions will reduce the financial strain on customers, the company added.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show